These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6663764)

  • 1. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 3. Preclinical evaluation of the urinary NAG activity and changes in diabetic patients].
    Iimura Y; Shimada I; Ohnuki Y; Kawai T; Sakamoto Y
    Rinsho Byori; 1983 Sep; Spec No 56():79-89. PubMed ID: 6663764
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from he kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 5. Preclinical evaluation of the urinary NAG activity and its fluctuations in kidney and liver diseases and diabetes mellitus].
    Kin K; Akiyoshi R; Ohashi M; Nihonyanagi Y
    Rinsho Byori; 1983 Sep; Spec No 56():102-10. PubMed ID: 6663751
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 6. Preclinical evaluation of the urinary NAG activity and its relation to kidney function tests].
    Sano K; Uno E
    Rinsho Byori; 1983 Sep; Spec No 56():111-21. PubMed ID: 6663752
    [No Abstract]   [Full Text] [Related]  

  • 4. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 2. Preclinical determination of the urinary NAG activities and the test data of patients admitted for multiphasic screening].
    Kiyose H; Tomii M; Shimomura H; Mizuno E; Taguchi I; Inoue Y
    Rinsho Byori; 1983 Sep; Spec No 56():73-8. PubMed ID: 6663763
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 4. Preclinical evaluation of the urinary NAG activity and changes in renal diseases].
    Yakata M; Sugita O; Sakai T; Uchiyama K; Wada K
    Rinsho Byori; 1983 Sep; Spec No 56():90-101. PubMed ID: 6663765
    [No Abstract]   [Full Text] [Related]  

  • 6. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 8. Preclinical evaluation of the urinary NAG activities and their fluctuations in kidney diseases].
    Ishida M; Fujino N; Maeba T; Sugiyama M; Kanazawa T; Owada S; Inoue T; Ozawa S; Amakawa T
    Rinsho Byori; 1983 Sep; Spec No 56():132-8. PubMed ID: 6663754
    [No Abstract]   [Full Text] [Related]  

  • 7. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 7. Preclinical evaluation of urinary NAG activity and its fluctuations in primary glomerulonephritis].
    Soejima A; Nagasawa T
    Rinsho Byori; 1983 Sep; Spec No 56():122-31. PubMed ID: 6663753
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 1. Description of NAG activity determination].
    Noto A; Mori S; Nakamura M; Kitakaze T
    Rinsho Byori; 1983 Sep; Spec No 56():65-72. PubMed ID: 6663762
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 11. Clinical significance of urinary NAG activity in patients with kidney diseases and those with kidney homografts].
    Ishida Y; Kawada T; Sugino N
    Rinsho Byori; 1983 Sep; Spec No 56():160-7. PubMed ID: 6363758
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 10. Clinical significance of urinary NAG activity in patients with kidney diseases, with special reference to nephrotic syndrome and antibiotic treatment].
    Ishimoto F; Shibazaki T; Murai S; Kodama K; Ohno I; Gomi H
    Rinsho Byori; 1983 Sep; Spec No 56():147-59. PubMed ID: 6663756
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 12. Fluctuations of urinary NAG activities in postcardiotomy renal tubular impairment].
    Nagahama D; Tabata K; Yasuma F
    Rinsho Byori; 1983 Sep; Spec No 56():168-80. PubMed ID: 6663757
    [No Abstract]   [Full Text] [Related]  

  • 12. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 9. Clinical study of urinary NAG activity in patients with various kidney diseases].
    Suzuki M; Asano Y
    Rinsho Byori; 1983 Sep; Spec No 56():139-46. PubMed ID: 6663755
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) during follow-up period and related factors in diabetic patients].
    Arao M; Matsumiya K; Hasegawa K; Horiuchi N; Sasaki A
    Rinsho Byori; 1989 Jan; 37(1):37-42. PubMed ID: 2724580
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary N-acetyl-beta-D-glucosaminidase in the patients with hyperthyroidism.
    Tominaga M; Fujiyama K; Hoshino T; Tanaka Y; Takeuchi T; Honda M; Mokuda O; Ikeda T; Mashiba H
    Horm Metab Res; 1989 Aug; 21(8):438-40. PubMed ID: 2793065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine and serum leucine aminopeptidase, N-acetyl-beta-glucosaminidase and gamma-glutamyl transpeptidase activities in diabetics with and without nephropathy.
    Cohen N; Gertler A; Atar H; Bar-Khayim Y
    Isr J Med Sci; 1981 Jun; 17(6):422-5. PubMed ID: 6114940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T; Hirokawa N; Oike S; Maekawa T
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of urinary N-acetyl-beta-D-glucosaminidase for predicting early stage diabetic nephropathy.
    Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
    Int J Clin Pract; 1997; 51(8):489-90. PubMed ID: 9536599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early diagnosis of renal ischemia in arterial hypertension by means of urine N-acetyl-beta-D-glucosaminidase (author's transl)].
    García M; Méndez X; Botey A; Pons JM; Revert L
    Med Clin (Barc); 1981 Sep; 77(5):200-4. PubMed ID: 7329141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary N-acetyl-beta-D-glucosaminidase and incipient diabetic nephropathy].
    Wang XD
    Zhonghua Yi Xue Za Zhi; 1988 Apr; 68(4):215-7. PubMed ID: 3196940
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
    Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
    Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.